Article Ancel et al., 2023

Ancel J., Dormoy V., Raby B. N., Dalstein V., Durlach A., Dewolf M., Gilles C., Polette M., Deslée G. (2023). Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors. Frontiers in Immunology, 14. DOI: 10.3389/fimmu.2023.1171649. Réf. HAL: hal-04179091 - OA HAL

Deslee G., Fabry-Vendrand C., Poccardi N., Thabut G., Eteve Pitsaer C., Coriat A., Renaudat C., Maguire A., Pinto T. (2023). Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study). BMJ open respiratory research, 10(1)e001585. DOI: https://doi.org/10.1136/bmjresp-2022-001585. Réf. HAL: hal-04179123 - OA HAL

Article Deslee et al., 2023
Article Muggeo et al., 2023

Muggeo A., Coraux C., Guillard T. (2023). Current concepts on Pseudomonas aeruginosa interaction with human airway epithelium. PLoS Pathogens, 19(3)e1011221. DOI: https://doi.org/10.1371/journal.ppat.1011221. Réf. HAL: hal-04065670 - OA HAL

L’unité UMR-S 1250 est lauréate de l’appel à projet thématique exceptionnel « Epithélium Respiratoire 2022 »

Fondation du souffle et AstraZeneca